COM:ACURXPHARMA
Acurx Pharmaceuticals, Inc.
- Stock
Last Close
2.21
30/08 20:00
Market Cap
34.97M
Beta: -
Volume Today
31.32K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '20 | Jun '20 | Sep '20 | Dec '20 | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -1.28M - | -913.36K 28.59% | -1.31M 43.92% | -1.09M 16.85% | -1.47M 34.88% | -4.00M 171.59% | -4.64M 15.94% | -2.63M 43.41% | -2.67M 1.64% | -2.62M 1.86% | -3.54M 35.15% | -3.26M 7.94% | -2.90M 10.97% | -3.45M 18.68% | -3.11M 9.59% | -5.11M 64.19% | -4.38M 14.40% | -4.12M 5.85% | |
depreciation and amortization | |||||||||||||||||||
deferred income tax | |||||||||||||||||||
stock based compensation | 347.77K - | 327.76K 5.75% | 306.64K 6.44% | 285.77K 6.81% | 327.14K 14.48% | 2.26M 590.01% | 3.40M 50.53% | 760.14K 77.63% | 949.17K 24.87% | 716.68K 24.49% | 824.04K 14.98% | 812.47K 1.41% | 899.38K 10.70% | 806.49K 10.33% | 833.28K 3.32% | 833.28K 0% | 894.52M 107,248.99% | ||
change in working capital | -749.66K - | -148.15K 80.24% | 249.14K 268.17% | -152.50K 161.21% | -316.71K 107.69% | 1.48M 568.40% | -1.39M 193.85% | 366.75K 126.34% | -155.03K 142.27% | -86.80K 44.01% | 537.50K 719.24% | 952.46K 77.20% | 70.65K 92.58% | 1.06M 1,403.28% | 188.19K 82.28% | -310.15K 264.81% | 114.83K 137.02% | 11.05K 90.38% | |
accounts receivables | 129.16K - | -51.13K 139.58% | |||||||||||||||||
inventory | |||||||||||||||||||
accounts payables | 387.98K - | -210.88M 54,453.86% | -370.03K 99.82% | 1.22M - | 12.30M 909.79% | 67.80M - | |||||||||||||
other working capital | 1.48M - | -21.23K - | 210.73M 992,779.33% | 283.23K 99.87% | 537.50K 89.77% | -265.32K 149.36% | -12.30M 4,534.80% | 1.06M 108.64% | 188.19K 82.28% | -310.15K 264.81% | -14.33K 95.38% | 62.18K 533.95% | |||||||
other non cash items | 781.70K - | 916.76K - | -66.50K 107.25% | 393.68K - | 1.07M 172.04% | 1.28M 19.67% | |||||||||||||
net cash provided by operating activities | -899.29K - | -733.75K 18.41% | -758.76K 3.41% | -959.75K 26.49% | -547.14K 42.99% | -329.81K 39.72% | -2.64M 699.42% | -1.50M 43.10% | -1.88M 25.05% | -1.99M 6.11% | -2.18M 9.51% | -1.50M 31.40% | -1.93M 29.24% | -1.58M 18.43% | -2.09M 32.78% | -4.20M 100.51% | -3.06M 27.03% | -2.88M 5.96% | |
investments in property plant and equipment | |||||||||||||||||||
acquisitions net | |||||||||||||||||||
purchases of investments | |||||||||||||||||||
sales maturities of investments | |||||||||||||||||||
other investing activites | |||||||||||||||||||
net cash used for investing activites | |||||||||||||||||||
debt repayment | |||||||||||||||||||
common stock issued | 1.06M - | 2.19M 107.15% | 728.54K 66.75% | 14.80M - | -14.80M - | 3.70M - | 3.70M 0.00% | 3.54M - | 2.40M - | 4.30M 79.10% | 320.21K 92.55% | ||||||||
common stock repurchased | -0.00 - | ||||||||||||||||||
dividends paid | |||||||||||||||||||
other financing activites | 66.50K - | 29.53M - | -3.70M - | 73 - | 2.22M - | 210.20K 90.53% | |||||||||||||
net cash used provided by financing activities | 1.12M - | 2.19M 94.90% | 728.54K 66.75% | 14.80M - | 14.73M - | 3.70M - | -1 100.00% | 3.54M - | 4.62M - | 4.51M 2.38% | 320.21K 92.90% | ||||||||
effect of forex changes on cash | |||||||||||||||||||
net change in cash | -899.29K - | 390.41K 143.41% | 1.43M 266.84% | -231.22K 116.14% | -547.14K 136.63% | 14.47M 2,744.18% | -2.64M 118.22% | -1.50M 43.10% | -1.88M 25.05% | -1.99M 6.11% | 1.52M 176.11% | -1.50M 198.71% | -1.93M 29.24% | -8.76M 352.96% | -2.09M 76.09% | 421.86K 120.15% | 1.45M 242.94% | -2.56M 276.95% | |
cash at beginning of period | 2.48M - | 1.58M 36.21% | 1.97M 24.65% | 3.41M 72.54% | 3.18M 6.79% | 2.63M 17.23% | 17.10M 550.45% | 14.46M 15.42% | 12.96M 10.38% | 11.08M 14.48% | 9.09M 17.96% | 10.61M 16.66% | 9.11M 14.10% | 7.18M 21.21% | 9.15M 27.40% | 7.05M 22.89% | 7.47M 5.98% | 8.92M 19.36% | |
cash at end of period | 1.58M - | 1.97M 24.65% | 3.41M 72.54% | 3.18M 6.79% | 2.63M 17.23% | 17.10M 550.45% | 14.46M 15.42% | 12.96M 10.38% | 11.08M 14.48% | 9.09M 17.96% | 10.61M 16.66% | 9.11M 14.10% | 7.18M 21.21% | -1.58M 121.96% | 7.05M 547.29% | 7.47M 5.98% | 8.92M 19.36% | 6.36M 28.70% | |
operating cash flow | -899.29K - | -733.75K 18.41% | -758.76K 3.41% | -959.75K 26.49% | -547.14K 42.99% | -329.81K 39.72% | -2.64M 699.42% | -1.50M 43.10% | -1.88M 25.05% | -1.99M 6.11% | -2.18M 9.51% | -1.50M 31.40% | -1.93M 29.24% | -1.58M 18.43% | -2.09M 32.78% | -4.20M 100.51% | -3.06M 27.03% | -2.88M 5.96% | |
capital expenditure | |||||||||||||||||||
free cash flow | -899.29K - | -733.75K 18.41% | -758.76K 3.41% | -959.75K 26.49% | -547.14K 42.99% | -329.81K 39.72% | -2.64M 699.42% | -1.50M 43.10% | -1.88M 25.05% | -1.99M 6.11% | -2.18M 9.51% | -1.50M 31.40% | -1.93M 29.24% | -1.58M 18.43% | -2.09M 32.78% | -4.20M 100.51% | -3.06M 27.03% | -2.88M 5.96% |
All numbers in (except ratios and percentages)